|
The document outlines a proposed blood sampling program for employees at Mitsui Fluorochemicals Co. Ltd. in Japan to assess potential exposure to C-8 (perfluorooctanoic acid, PFOA) by comparing dispersing agent values at their facility with those at DuPont's Washington Works, where C-8 has been used for over 25 years.
|
— |
AR226-1600
|
YGJkzz8Rv3xQVX5GVo6nVxp3n |
5 |